Your browser doesn't support javascript.
loading
Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52.
Joshi, Jugal Bharat; Patel, Divya; Morton, Derrick J; Sharma, Pankaj; Zou, Jin; Hewa Bostanthirige, Dhanushka; Gorantla, Yamini; Nagappan, Peri; Komaragiri, Shravan Kumar; Sivils, Jeffrey C; Xie, Huan; Palaniappan, Ravi; Wang, Guangdi; Cox, Marc B; Chaudhary, Jaideep.
Afiliação
  • Joshi JB; Center for Cancer Research and Therapeutic Development, Clark Atlanta University, GA, USA.
  • Patel D; Center for Cancer Research and Therapeutic Development, Clark Atlanta University, GA, USA.
  • Morton DJ; Center for Cancer Research and Therapeutic Development, Clark Atlanta University, GA, USA.
  • Sharma P; Center for Cancer Research and Therapeutic Development, Clark Atlanta University, GA, USA.
  • Zou J; Center for Cancer Research and Therapeutic Development, Clark Atlanta University, GA, USA.
  • Hewa Bostanthirige D; Center for Cancer Research and Therapeutic Development, Clark Atlanta University, GA, USA.
  • Gorantla Y; College of Pharmacy, Mercer University, Atlanta, GA, USA.
  • Nagappan P; Center for Cancer Research and Therapeutic Development, Clark Atlanta University, GA, USA.
  • Komaragiri SK; Center for Cancer Research and Therapeutic Development, Clark Atlanta University, GA, USA.
  • Sivils JC; Department of Biological Sciences, Border Biomedical Research Center, University of Texas at El Paso, TX, USA.
  • Xie H; College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, USA.
  • Palaniappan R; College of Pharmacy, Mercer University, Atlanta, GA, USA.
  • Wang G; Department of Chemistry, RCMI Cancer Research Center, Xavier University of Louisiana, New Orleans, LA, USA.
  • Cox MB; Department of Biological Sciences, Border Biomedical Research Center, University of Texas at El Paso, TX, USA.
  • Chaudhary J; Center for Cancer Research and Therapeutic Development, Clark Atlanta University, GA, USA.
Mol Oncol ; 11(4): 337-357, 2017 04.
Article em En | MEDLINE | ID: mdl-28252832
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Androgênicos / Proteínas de Ligação a Tacrolimo / Proteínas Inibidoras de Diferenciação / Neoplasias de Próstata Resistentes à Castração Limite: Animals / Humans / Male Idioma: En Revista: Mol Oncol Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Androgênicos / Proteínas de Ligação a Tacrolimo / Proteínas Inibidoras de Diferenciação / Neoplasias de Próstata Resistentes à Castração Limite: Animals / Humans / Male Idioma: En Revista: Mol Oncol Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos